期刊文献+

共载姜黄素与阿霉素胶束的制备工艺优化及体外抗肿瘤评价 被引量:2

Optimization of preparation and in vitro anti-tumor evaluation of CUR/DOX micelles
下载PDF
导出
摘要 目的 制备共载姜黄素/阿霉素聚己内酯-聚乙二醇-聚己内酯胶束(CUR/DOX micelle),优化其制备工艺,并进行体外抗肿瘤评价。方法 采用薄膜-水化-超声法制备CUR/DOX micelle,以粒径、包封率和载药量为评价指标,采用正交设计优化纳米粒处方;对胶束进行表征,透射电镜观察胶束的外观形态,测定其粒径大小及分布,并测定包封率及载药量;考察其稳定性和体外释药特性;体外抗肿瘤评价中,流式细胞仪考察CUR/DOX micelle的细胞摄取率,MTT法考察其对肿瘤细胞的抑制作用。结果 CUR/DOX micelle的最佳制备工艺为:药物和聚己内酯-聚乙二醇-聚己内酯(PCL-PEG-PCL)比例为1∶10,水化温度为65℃,超声时间为6 min;制得的胶束平均粒径为150 nm,TEM结果显示胶束呈球形;姜黄素的包封率为85.21%,载药量为6.80%,阿霉素的包封率为82.92%,载药量为1.28%;CUR/DOX micelle具有良好的稳定性和缓释能力;体外细胞实验结果显示,CUR/DOX micelle细胞摄取率升高,能有效抑制人乳腺癌MCF-7细胞的增殖。结论 CUR/DOX micelle制备工艺简单且稳定性好,能有效增强药物的体外抗肿瘤活性。 Objective To prepare curcumin and doxorubicin loaded PCL-PEG-PCL micelle(CUR/DOX micelles), optimize the preparation, and evaluate the anti-tumor activity of CUR/DOX micelles in vitro. Methods The CUR/DOX micelles were prepared by thin film-hydration-ultrasound method.The preparation technology was optimized by orthogonal test with the particle size, encapsulation efficiency and drug loading as the evaluation parameters. The morphology imaging of CUR/DOX micelles was observed by transmission electron microscopy. The particle size was conducted by a nanoparticle analyzer. The drug-loading rate and encapsulation efficiency of micelle were determined.The stability and release profile in vitro were determined. The cellular uptake of CUR/DOX micelles was measured by flow cytometry and the cytotoxicity was determined by MTT in vitro. Results The optimal preparation of CUR/DOX micelles was as follows: the drug and PCL-PEG-PCL ratio was 1∶10, the hydration temperature was 65 ℃, and the ultrasound use for 6 min. The optimal mean diameter of micelles was around 150 nm at size and the TEM showed spherical morphology. The encapsulation efficiency and drug loading of curcumin were 85.21% and 6.80%;those of doxorubicin were 82.92% and 1.28%, respectively. The CUR/DOX micelles exhibited good stability and sustained release. In vitro experiments showed CUR/DOX micelles increased the cellular uptake efficiency and enhanced the cytotoxicity in MCF-7 cells effectively. Conclusion The preparation method is simple and stable, and CUR/DOX micelles can enhance the anti-tumor activity significantly.
作者 李芳婵 韦志英 罗小莉 潘翠柳 吴秀彩 梁方耀 潘真真 李耀华 LI Fang-chan;WEI Zhi-ying;LUO Xiao-li;PAN Cui-liu;WU Xiu-cai;LIANG Fang-yao;PAN Zhen-zhen;LI Yao-hua(Guangxi University of Chinese Medicine,Experimental Teaching Center,Nanning 530200;Key Laboratory of TCM Extraction and Purification and Quality Analysis(Guangxi University of Chinese Medicine),Education Department of Guangxi Zhuang Autonomous Region,Nanning 530200;Guangxi University of Chinese Medicine,College of Pharmacy,Nanning 530200)
出处 《中南药学》 CAS 2023年第2期449-455,共7页 Central South Pharmacy
基金 广西高校中青年教师科研基础能力提升项目(No.2019KY0333) 广西高校中青年教师科研基础能力提升项目(No.2020KY07037) 广西中医药大学校级课题(No.2019QN006)。
关键词 姜黄素 阿霉素 胶束 抗肿瘤活性 curcumin doxorubicin micelle anti-tumor activity
  • 相关文献

参考文献4

二级参考文献22

  • 1Vander HR, Jacobs DI, Snoeijer W, et al. The Catharus alkaloids : pharmacognosy and biotechnology [ J ]. Cur Med Chem, 2004,11(5) :607 -608.
  • 2Wan CK,Zhu GY,Shen XL,et al. Gomisin A alters substrate interaction and reverses P-glycoprotein-mediated multidrug resistance in HepG2-DR cells [ J ]. Biochem Pharmacol, 2006,72 (7) :824 -837.
  • 3Hu Y, Zhang L, Cao Y,et al. Degradation behavior of poly ( ε-caprolactone) -b-poly ( ethyleneglycol ) -b-poly ( ε-caprolactone ) micelles in aqueous solution [J]. Biomacromolecules, 2004,5 (5):1 756-1 762.
  • 4Petrak K. Design and properties of particulate carriers for intravascular administration [ J ]. Drug Pharm Sci, 1993,61 ( 2 ) :275 - 297.
  • 5Allen TM. The use of glycolipids and hydrophilic polymers in avoiding rapid-take of liposomes by the mononuclear phagocyte system [ J ]. Adv Drug Deliv Rev, 1994,13 ( 3 ) : 185 - 309.
  • 6Bazile D, Prudhomme C, Bassoullet MT, et al. Stealth MePEGPLA nanoparticles avoid uptake by the mononuclear phagocytes system[J]. J Pharm Sci,1995,84(4) :493 -498.
  • 7Kataoka K, Kwon GS, Yokoyama M, et al. Block copolymer micelles as vehicles for drug delivery [ J ]. J Control Release, 1993, 24(1-3) :119 -132.
  • 8Shin IG, Kim SY, Lee YM, et al. Methoxy poly (ethylene glycol)/e-caprolactone amphiphilic block copolymeric micelle con- taining indomethacin. Ⅰ. Preparation and characterization [ J ]. J Control Release, 1998,51 ( 1 ) : 1 - 11.
  • 9Hu Y,Jiang XQ,Ding Yet al. Preparation and drug release behaviors of nimodipine-loaded poly ( caprolactone ) -poly ( ethylene oxide ) -polylactide amphiphilic copolymer nanoparticles [ J ]. Biomaterials ,2003,24 ( 13 ) :2 395 - 2 404.
  • 10Win KY, Feng SS. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs[J]. Biomaterials,2005,26(15) :2 713 -2 722.

共引文献85

同被引文献6

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部